Pathology and Genetics of Familial Gastric Cancer

Guilford P , Hopkins J , Harraway J . E-cadherin germline mutations in familial gastric cancer. Nature. 1998; 392: 402–405.

Caldas C , Carneiro F , Lynch HT . Familial gastric cancer: overview and guidelines for management. J Med Genet. 1999; 36: 873–880.

Fitzgerald RC , Hardwick R , Huntsman D , Carneiro F , Guilford P , Blair V . (on behalf of the International Gastric Cancer Linkage Consortium). Hereditary diffuse gastric cancer: Updated consensus guidelines for clinical management and directions for future research. J Med Genet (in press, 2010).

Guilford PJ , Hopkins JB , Grady WM . E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat. 1999; 14: 249–255.

Richards FM , McKee SA , Rajpar MH . Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet. 1999; 8: 607–610.

Huntsman DG , Carneiro F , Lewis FR . Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med. 2001; 344: 1904–1909.

Caldas C , Carneiro F , Lynch HT . Familial gastric cancer: overview and guidelines for management. J Med Genet. 1999; 36: 873–880.

Blair V , Martin I , Shaw D . Hereditary diffuse gastric cancer: diagnosis and management. Clin Gastroenterol Hepatol. 2006; 4: 262–275.

Oliveira C , Senz J , Kaurah P . Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet. 2009; 18: 1545–1555.

Oliveira C , Seruca R , Carneiro F . Hereditary gastric cancer. Best Pract Res Clin Gastroenterol. 2009; 23: 147–157.

Kaurah P , MacMillan A , Boyd N . Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA. 2007; 297: 2360–2372.

Carneiro F , Oliveira C , Suriano G , Seruca R . Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer. J Clin Pathol. 2008; 61: 25–30.

Suriano G , Oliveira MJ , Huntsman D . E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells. Hum Mol Genet. 2003; 12: 3007–3016.

Grady WM , Willis J , Guilford PJ . Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet. 2000; 26: 16–17.

Oliveira C , Sousa S , Pinheiro H . Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroen-terology. 2009; 136: 2137–2148.

Barber M , Murrell A , Ito Y . Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer. J Pathol. 2008; 216: 295–306.

Oliveira C , de Bruin J , Nabais S . Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in a HDGC tumour. Oncogene, 2004; 23: 2236–2240.

Humar B , Fukuzawa R , Blair V . Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer. Cancer Res. 2007; 67: 2480–2489.

Oliveira C , Ferreira P , Nabais S . E-cadherin (CDH1) and TP53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients. Eur J Cancer. 2004; 40: 1897–1903.

Keller G , Vogelsang H , Becker I . Germline mutations of the E-cadherin (CDH1) and TP53 genes rather than of RUNX3 and HPP1 contribute to genetic predisposition in German gastric cancer patients. J Med Genet. 2004; 41: e89.

Shaw D , Blair V , Framp A . Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy? Gut. 2005; 54: 461–468.

Chun YS , Lindor NM , Smyrk TC . Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated? Cancer. 2001; 92: 181–187.

Charlton A , Blair V , Shaw D , Parry S , Guilford P , Martin IG . Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Gut 2004; 53: 814–820.

Carneiro F , Huntsman DG , Smyrk TC . Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol. 2004; 203: 681–687.

Barber ME , Save V , Carneiro F . Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk. J Pathol. 2008; 216: 286–294.

Rogers WM , Dobo E , Norton JA . Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications. Am J Surg Pathol. 2008; 32: 799–809.

Norton JA , Ham CM , Van Dam J . CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Ann Surg. 2007; 245: 873–879.

Hebbard PC , Macmillan A , Huntsman D . Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients. Ann Surg Oncol. 2009; 16: 1890–1895.